Search results
3 Reasons to Buy Moderna Stock
The Motley Fool via AOL· 7 hours agoNot at all. Let's consider three reasons why investing in the company today is worth it. MRNA data by YCharts. 1. Moderna launches its first non-COVID...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 3 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 1 day agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Fighting Words in a COVID-19 Pandemic—Combating an Era of Denialism
Newsweek· 2 days agoHippocrates tells us, "Primum non nocere," or "First do no harm." Recent testimony in Congress has...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 4 days agoA different type of cancer vaccine is being tested in patients who already have cancer ‒ though it's...
The Evolution of Vaccinology: From Humble Beginnings to Advanced Science | JD Supra
JD Supra· 2 days agoFor centuries, humans have sought ways to protect from deadly diseases. The practice of intentionally exposing healthy people to smallpox, a practice...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 1 day agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 3 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
